The clinical question of mepolizumab in the long-term treatment of idiopathic chronic eosinophilic pneumonia; how long should we use mepolizumab?
2024 · Respiratory Medicine Case Reports · 0 citations
https://doi.org/10.1016/j.rmcr.2024.102142
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
28
Papers
112
Citations
5
h-index
3
i10-index
Masamitsu Hamakawa is an academic researcher from Kurashiki Central Hospital. The author has contributed to research in topics: Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis & Medical Imaging and Pathology Studies & Asthma and respiratory diseases. The author has an h-index of 5, co-authored 24 publications.
ORCID: 0009-0002-4635-4034https://doi.org/10.1016/j.rmcr.2024.102142
https://doi.org/10.1016/j.rmcr.2025.102350
Click to start Chat